全文获取类型
收费全文 | 1522610篇 |
免费 | 118020篇 |
国内免费 | 21995篇 |
学科分类
医药卫生 | 1662625篇 |
出版年
2021年 | 21048篇 |
2020年 | 15267篇 |
2019年 | 17116篇 |
2018年 | 21275篇 |
2017年 | 17268篇 |
2016年 | 17973篇 |
2015年 | 23547篇 |
2014年 | 30629篇 |
2013年 | 36547篇 |
2012年 | 51772篇 |
2011年 | 57009篇 |
2010年 | 33970篇 |
2009年 | 29846篇 |
2008年 | 47956篇 |
2007年 | 50949篇 |
2006年 | 51714篇 |
2005年 | 51352篇 |
2004年 | 44344篇 |
2003年 | 42786篇 |
2002年 | 41076篇 |
2001年 | 63264篇 |
2000年 | 65507篇 |
1999年 | 57450篇 |
1998年 | 18801篇 |
1997年 | 17430篇 |
1996年 | 16690篇 |
1995年 | 15806篇 |
1994年 | 14613篇 |
1993年 | 12778篇 |
1992年 | 43006篇 |
1991年 | 42081篇 |
1990年 | 41312篇 |
1989年 | 39900篇 |
1988年 | 37110篇 |
1987年 | 36167篇 |
1986年 | 34351篇 |
1985年 | 32648篇 |
1984年 | 24205篇 |
1983年 | 20961篇 |
1979年 | 22677篇 |
1978年 | 15832篇 |
1977年 | 13684篇 |
1976年 | 12932篇 |
1975年 | 14165篇 |
1974年 | 16659篇 |
1973年 | 16042篇 |
1972年 | 15306篇 |
1971年 | 14222篇 |
1970年 | 13202篇 |
1969年 | 12720篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
D1 dopamine receptors in the rat retina: effect of dark adaptation and chronic blockade by SCH 23390
Chronic administration of SCH 23390 (0.03 mg/kg s.c., three times daily), a selective D1 dopamine (DA) receptor blocker, markedly increased the [3H]SCH 23390 binding in the rat retina. As revealed by the Scatchard plot analysis of saturation data from retinal homogenates, chronic SCH 23390 increased the total number of binding sites by 34% when compared to tissue from solvent-treated rats but failed to change the apparent affinity of [3H]SCH 23390 for its binding sites. The up-regulation of [3H]SCH 23390 binding sites was paralleled by an increase in the sensitivity of retina DA-sensitive adenylate cyclase. In fact, DA (5 X 10(-6) M to 10(-4) M) produced a higher accumulation of cyclic AMP (from 58 to 128%) in the retina of SCH 23390-treated rats as compared to the accumulation (from 35 to 80%) found in tissue from solvent-treated rats. Since dark adaptation decreases dopaminergic function in the rat retina, the influence of environmental lighting on [3H]SCH 23390 binding and DA-sensitive adenylate cyclase activity was studied. After 4 h of dark adaptation the density of [3H]SCH 23390 binding sites was higher (32%) than that from light-adapted rats. On the other hand, dark adaptation failed to change the apparent affinity of [3H]SCH 23390 for its binding sites. Moreover, DA elicited a greater stimulation of adenylate cyclase activity in homogenates of retina from dark-adapted rats. Thus, the maximum adenylate cyclase response to DA resulted higher in the retina of dark-adapted rats (152%) than that found in the retina of light-adapted animals (97%).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
992.
A significant increase of LDL-apolipoprotein B by 13% and LDL-cholesterol by 19% was observed in a group of 9 patients with hyperlipoproteinaemia Type III after bezafibrate treatment. Additional administration of colestipol caused a significant decrease of both LDL-apolipoprotein B by 18% and LDL-cholesterol by 25%. In 10 patients of hyperlipoproteinaemia Type IIb a significant decrease of both LDL-apolipoprotein B by 28% and LDL-apolipoprotein B by 18% was observed after bezafibrate therapy. When bezafibrate was given together with colestipol a further decrease of both LDL-cholesterol by 17% and LDL-apolipoprotein B by 16% occurred. HDL-cholesterol concentration increased significantly in both groups of hyperlipaemic patients during therapy. This may be the effect of both bezafibrate and colestipol. It is concluded that bile acid resins may effectively prevent the LDL-cholesterol concentration increase observed sometimes after clofibrate analogues. 相似文献
993.
994.
995.
996.
997.
998.
P A Fantoni C Baroni G Lazzarini M Astuni S Tognoli V Barbieri 《Minerva chirurgica》1986,41(10):923-930
999.
Electrical stimulation of rat habenular complex induces analgesia, evaluated by the tail-flick test, dependent on intensity of stimulation with a long post-effect, that is reversible by naloxone and without behavior effects at less that 400 mA. Bilateral destruction of habenula fails to provoke hyperesthesia but causes more marked long-term tolerance effects than in controls. Anatomy suggests that the habenula activates an inhibitory descending system in the spinal cord with a probable relay in the dorsal raphe and involving an endogenous opioid-dependent stage. 相似文献
1000.